Lysis of Epidural Lesions
Customize your policy alerts
Sign up for Centene Policy CP MP.116 alerts
Get alerted when Policy CP MP.116 changes without checking for updates manually.
Monitor payer policy activity
Defines Centene's coverage stance and criteria for percutaneous and endoscopic lysis of epidural adhesions (epidural adhesiolysis) for members with chronic low back and lower extremity pain. Applies to providers submitting claims to Centene-affiliated health plans.
No material clinical or coverage changes in this revision.
Coverage Determination and Criteria
General coverage determination
Covered when ALL of the following are met:
This is the explicit coverage conclusion of the policy.
It is the policy of Centene-affiliated health plans that lysis of epidural lesions — including percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without use of an indwelling epidural Racz catheter — is not supported by current medical literature and therefore is excluded from coverage.
Although a Hayes review identified six randomized controlled trials and reported limited, low-quality evidence suggesting potential short- and intermediate-term benefit of percutaneous adhesiolysis in select patients who have failed conservative therapy, the evidence base is small, of limited quality, and characterized by uncertain long-term outcomes. For these reasons, and because the overall literature does not reliably demonstrate efficacy, the procedure is considered not supported by current evidence and is not covered under this policy.
Coding References
| 62263 | Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days. |
| 62264 | Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day. |
Provider Responsibilities and Billing Guidance
Prior authorization required for CPT 62263 / 62264
Obtain prior authorization per plan rules when requesting services billed with CPT 62263 or 62264, because the policy states coverage is restricted by the policy stance that current medical literature does not support efficacy for lysis of epidural lesions.
Conservative therapy failure is noted in the evidence but policy finds insufficient efficacy
Although studies and guideline summaries commonly evaluate adhesiolysis after failure of conservative therapy, the policy concludes that current literature does not support the efficacy of lysis of epidural lesions.
- Supporting evidence (Hayes review and guideline updates) often describes patient populations with prior conservative treatment failures.
- Policy outcome: despite that context, the literature is judged not supportive of efficacy.
Coverage denial risk due to lack of supportive literature
Be aware claims for percutaneous or endoscopic lysis of epidural adhesions may be denied because the policy states current medical literature does not support the efficacy of these procedures.
- Policy explicitly states procedures for lysis of epidural lesions are not supported by current literature and are excluded from coverage.
- Denial risk applies to percutaneous adhesiolysis, endoscopic adhesiolysis, and procedures with or without an indwelling Racz catheter.
Clinical Background
Epidural adhesiolysis is performed to mechanically or chemically disrupt epidural scar and adhesions that may contribute to chronic low back and radicular pain, commonly in patients with prior spinal surgery (failed back surgery/post‑laminectomy syndromes) or degenerative spinal disease. Techniques include percutaneous catheter-based disruption and injection (often using agents such as hypertonic saline, steroids, analgesics, or hyaluronidase) with fluoroscopic localization, as well as endoscopic epidural adhesiolysis (epiduroscopy), which uses spinal endoscopy to directly visualize and mechanically divide adhesions and deliver targeted injectate to affected nerve roots.
Definitions of Techniques
Role of Prior Conservative Therapy in Evidence and Policy
Conservative treatment requirements (context)
Context from evidence and guidelines (informational; does not change the policy coverage conclusion):
Hayes review identified a small body of low-quality RCT evidence suggesting potential short- and intermediate-term benefit in patients who failed conservative therapy, but long-term outcomes are uncertain and evidence is limited. ASIPP guideline updates note limited high-quality RCTs and consider adhesiolysis in patients after failure of conservative treatment.
Procedure Frequency and Session Descriptions
Imaging and Visualization Requirements
Use fluoroscopy or endoscopic visualization as applicable
Epidural adhesiolysis procedures require radiologic localization—fluoroscopy for percutaneous techniques or endoscopic visualization for epiduroscopy—depending on the technique used.
Not Covered Procedures
Percutaneous and endoscopic epidural adhesiolysis procedures — including administration of hypertonic saline, use of hyaluronidase, mechanical catheter manipulation, and procedures performed under endoscopic visualization — are explicitly not covered because current medical literature does not support their efficacy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.